Connection

David Taber to Angiotensin II Type 1 Receptor Blockers

This is a "connection" page, showing publications David Taber has written about Angiotensin II Type 1 Receptor Blockers.
  1. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Ann Pharmacother. 2008 Jan; 42(1):116-20.
    View in: PubMed
    Score: 0.282
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.